Version of Record online: 12 DEC 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 57, Issue 2, pages 648–655, February 2013
How to Cite
Chaiteerakij, R., Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Mettler, T. A., Fredericksen, Z. S., Kim, W. R., Gores, G. J., Roberts, R. O., Olson, J. E., Therneau, T. M. and Roberts, L. R. (2013), Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk. Hepatology, 57: 648–655. doi: 10.1002/hep.26092
Potential conflict of interest: Nothing to report.
This work was supported by the National Institutes of Health (grant nos.: CA100882, CA128633, and CA165076), the Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567), the Mayo Clinic Cancer Center (CA15083), and the Mayo Foundation (to L.R.R.).
- Issue online: 5 FEB 2013
- Version of Record online: 12 DEC 2012
- Accepted manuscript online: 11 OCT 2012 01:30AM EST
- Manuscript Accepted: 24 SEP 2012
- Manuscript Received: 17 JUN 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26092_sm_SuppTable.doc||77K||Supporting Information Table|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.